Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
daniele.marinelli@uniroma1.it
Daniele Marinelli
Dottorando
Struttura:
DIPARTIMENTO DI MEDICINA SPERIMENTALE
E-mail:
daniele.marinelli@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
11P Reconstructing tumour evolution of single cells using both somatic mutations and copy-number alterations
ESMO OPEN
2023
167P Molecular analysis of gastrointestinal stromal tumor (GIST): The experience of Regina Elena National Cancer Institute
ESMO OPEN
2023
Surgical and survival outcomes with perioperative or neoadjuvant immune-checkpoint inhibitors combined with platinum-based chemotherapy in resectable NSCLC: A systematic review and meta-analysis of randomised clinical trials
CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY
2023
Training and telemedicine: the key to the palliative medicine specialist shortage?
BMJ SUPPORTIVE & PALLIATIVE CARE
2023
Analysis of predictive factors of unforeseen nodal metastases in resected clinical stage I NSCLC
FRONTIERS IN ONCOLOGY
2023
Analysis of molecular biomarkers in resected early-stage non-small cells lung cancer: a narrative review
CANCERS
2022
The potential role of genomic signature in stage II relapsed colorectal cancer (CRC) patients: a mono-institutional study
CANCER MANAGEMENT AND RESEARCH
2022
Advanced non-small-cell lung cancer: how to manage EGFR and HER2 exon 20 insertion mutation-positive disease
DRUGS IN CONTEXT
2022
127P {RAS}, {RAF} and {NF}1 oncogenic mutations in {KRAS}-mutated lung adenocarcinoma
ANNALS OF ONCOLOGY
2022
56P The prognostic role of {KRAS} mutations in patients with early-stage lung adenocarcinoma after robotic lobectomy and systematic lymphadenectomy
ANNALS OF ONCOLOGY
2022
Non-small-cell lung cancer: how to manage ALK-, ROS1- and NTRK-rearranged disease
DRUGS IN CONTEXT
2022
Palliative- and non-palliative indications for glucocorticoids use in course of immune-checkpoint inhibition. Current evidence and future perspectives
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
2021
Nodal upstaging evaluation after robotic-assisted lobectomy for early-stage non-small cell lung cancer compared to video-assisted thoracic surgery and thoracotomy: a retrospective single center analysis
FRONTIERS IN SURGERY
2021
KEAP1 and TP53 frame genomic, evolutionary and immunological subtypes of lung adenocarcinoma with different sensitivity to immunotherapy
JOURNAL OF THORACIC ONCOLOGY
2021
Comparison of two blood-based genotyping tests to investigate the KRAS G12C mutation in patients with non-small-cell lung cancer at failure of first-line treatments
DIAGNOSTICS
2021
MicroRNA-based signatures impacting clinical course and biology of ovarian cancer: a miRNOmics study
BIOMARKER RESEARCH
2021
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial
SCIENTIFIC REPORTS
2021
Prognostic relevance of neutrophil to lymphocyte ratio (Nlr) in luminal breast cancer: A retrospective analysis in the neoadjuvant setting
CELLS
2021
Circulating hpv dna in the management of oropharyngeal and cervical cancers: Current knowledge and future perspectives
JOURNAL OF CLINICAL MEDICINE
2021
COVID-19 risk in breast cancer patients receiving CDK4/6 inhibitors: literature data and a monocentric experience
THE BREAST JOURNAL
2021
« prima
< precedente
1
2
3
seguente ›
ultima »
ERC
LS4_12
KET
Big data & computing
Life-science technologies & biotechnologies
Keywords
Non-small cell lung cancer (NSCLC)
cancer genomics
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma